Stephen Richard Baker

Title: Innovations of Stephen Richard Baker

Introduction

Stephen Richard Baker is an accomplished inventor based in Basingstoke, GB. He holds a total of 2 patents that focus on advancements in the field of acetylcholine receptor modulation. His work has significant implications for the treatment of dysfunctions in both the central and autonomic nervous systems.

Latest Patents

Baker's latest patents include "Aza-cyclic compounds as modulators of acetylcholine receptors." This invention discloses compounds that comprise an aza-cyclic portion and an aromatic portion linked via a sulphur atom. These compounds are selective modulators of the beta 4 subtype nicotinic acetylcholine receptors, making them useful for treating various dysfunctions of the nervous system. Another notable patent is "Modulators of acetylcholine receptors," which relates to compounds that enhance neurotransmission by promoting the release of neurotransmitters such as acetylcholine, dopamine, and norepinephrine. This invention specifically focuses on thio-bridged aryl compounds that can modulate acetylcholine receptors, offering potential therapeutic benefits.

Career Highlights

Stephen Richard Baker is currently associated with Merck & Co., Inc., where he continues to contribute to innovative research and development in pharmacology. His expertise in the modulation of neurotransmission has positioned him as a key figure in the field.

Collaborations

Baker has collaborated with notable colleagues, including Peter Charles Astles and Jean Michel Vernier, enhancing the scope and impact of his research.

Conclusion

Stephen Richard Baker's contributions to the field of acetylcholine receptor modulation demonstrate his commitment to advancing medical science. His patents reflect innovative approaches to treating nervous system dysfunctions, showcasing the importance of his work in the pharmaceutical industry.